Biopharma companies cut or planned to cut 6,956 employees in May 2026. This represented a 47% year-over-year increase in workforce reductions. Takeda and BioNTech together accounted for 6,360 of these job cuts. BioNTech announced 1,860 eliminations by late 2027, while Takeda plans 4,500 cuts in fiscal year 2026. Other companies like AbbVie, Amicus Therapeutics, Johnson & Johnson, Novartis, and Valneva also reported layoffs.
https://www.biospace.com/job-trends/may-layoffs-hit-nearly-7-000-with-most-cuts-from-takeda-biontech